Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine TAP block for recovery after cesarean section
ChiCTR2400080423Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine and bupivacaine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Postoperative recovery quality (QoR-15). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080423.